{"id":"W4390061629","doi":"10.1182/bloodadvances.2023011814","title":"Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; BeiGene; HistoGenetics; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Gateway for Cancer Research; CSL Behring; Bristol-Myers Squibb; Amgen; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Medicine; Hematopoietic cell; Internal medicine; Cyclophosphamide; Transplantation; Haematopoiesis; Stem cell; Chemotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003239449,0.0002989715,0.0005567001,0.0003913109,0.0001718746,0.0000554061,0.000168703,0.0001628111,0.0001053001],"category_scores_gemma":[0.0001263558,0.0002679079,0.0001526056,0.000745382,0.00006302068,0.0002616891,0.00002527964,0.000233204,0.0007780059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005669129,"about_ca_system_score_gemma":0.00005548523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002846473,"about_ca_topic_score_gemma":0.00006551645,"domain_scores_codex":[0.9975582,0.00007507072,0.0006311064,0.0006013076,0.0005594258,0.0005749293],"domain_scores_gemma":[0.9987175,0.0003120766,0.0001243901,0.0003460018,0.0001120887,0.0003878764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002237989,0.001739508,0.742466,0.002430334,0.001106138,0.003683846,0.01453965,0.0009648593,0.2239753,0.0009597612,0.0009609717,0.004935617],"study_design_scores_gemma":[0.02047216,0.001727198,0.5705768,0.01419856,0.003504286,0.00138668,0.00815597,0.000900868,0.3666065,0.001449035,0.008956413,0.002065518],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928906,0.0007487079,0.001752232,0.001757373,0.0005938042,0.00099092,0.0001005813,0.0005690096,0.0005967853],"genre_scores_gemma":[0.9918076,0.001662174,0.00392663,0.0002653677,0.0001724444,0.0002399933,0.0002095584,0.00006413405,0.001652124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1718892,"threshold_uncertainty_score":0.9999951,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02645697796824841,"score_gpt":0.306195066447848,"score_spread":0.2797380884795996,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}